Glutathione for detoxification and oxidative stress reduction
But these drugs are also being used to treat ob*sity on its own, too
This suggests that ghrelin may contribute to their increased appetite and body weight
A study of patients with non-alcoholic fatty liver disease (NAFLD) revealed that giving 300 mg of glutathione daily for four months resulted in significant reductions in elevated ALT (an enzyme associated with liver damage), triglycerides, and ferritin
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
For patients whose primary goal is visceral fat reduction, we use Tesamorelin, which is FDA-approved for that specific indication and has stronger clinical data for fat metabolism than sermorelin